Wellnex Life Ltd (WNX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wellnex Life Ltd (WNX) has a cash flow conversion efficiency ratio of 0.154x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.73 Million ≈ $1.22 Million USD) by net assets (AU$11.25 Million ≈ $7.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wellnex Life Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Wellnex Life Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Wellnex Life Ltd carry for a breakdown of total debt and financial obligations.
Wellnex Life Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellnex Life Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wi2Wi Corporation
V:YTY
|
-0.128x |
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
-0.719x |
|
Audeara Ltd
AU:AUA
|
0.024x |
|
Heavy Rare EARTHS Ltd
AU:HRE
|
-0.457x |
|
MPAY S.A. ZY-50
F:8NJ
|
N/A |
|
IDOX plc
LSE:IDOX
|
0.002x |
|
P/F Atlantic Petroleum
CO:ATLA-DKK
|
0.006x |
|
Madoro Metals Corp
V:MDM
|
-0.030x |
Annual Cash Flow Conversion Efficiency for Wellnex Life Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Wellnex Life Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see WNX company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$11.25 Million ≈ $7.96 Million |
AU$-666.00K ≈ $-471.24K |
-0.059x | +94.74% |
| 2023-12-31 | AU$6.06 Million ≈ $4.29 Million |
AU$-6.82 Million ≈ $-4.82 Million |
-1.125x | +89.20% |
| 2022-12-31 | AU$594.00K ≈ $420.29K |
AU$-6.19 Million ≈ $-4.38 Million |
-10.419x | -427.43% |
| 2021-12-31 | AU$4.36 Million ≈ $3.08 Million |
AU$-8.61 Million ≈ $-6.09 Million |
-1.975x | -111.24% |
| 2020-12-31 | AU$-249.00K ≈ $-176.18K |
AU$-4.38 Million ≈ $-3.10 Million |
17.574x | +754.92% |
| 2019-12-31 | AU$2.82 Million ≈ $2.00 Million |
AU$-7.57 Million ≈ $-5.36 Million |
-2.683x | -989.09% |
| 2018-12-31 | AU$51.44 Million ≈ $36.40 Million |
AU$-12.67 Million ≈ $-8.97 Million |
-0.246x | -150.25% |
| 2017-12-31 | AU$61.54 Million ≈ $43.54 Million |
AU$-6.06 Million ≈ $-4.29 Million |
-0.098x | +81.46% |
| 2016-12-31 | AU$6.98 Million ≈ $4.94 Million |
AU$-3.71 Million ≈ $-2.62 Million |
-0.531x | -704.96% |
| 2015-12-31 | AU$9.71 Million ≈ $6.87 Million |
AU$-640.63K ≈ $-453.29K |
-0.066x | -154.49% |
| 2014-12-31 | AU$-1.06 Million ≈ $-747.62K |
AU$-127.91K ≈ $-90.50K |
0.121x | +144.23% |
| 2013-12-31 | AU$-740.32K ≈ $-523.82K |
AU$202.64K ≈ $143.38K |
-0.274x | -- |
About Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth w… Read more